Journal article icon

Journal article

Peripherally-derived LGI1-reactive monoclonal antibodies cause epileptic seizures in vivo

Abstract:

One striking clinical hallmark in patients with autoantibodies to leucine-rich glioma inactivated 1 (LGI1) is the very frequent focal seizure semiologies, including faciobrachial dystonic seizures (FBDS), in addition to the amnesia. Polyclonal serum IgGs have successfully modelled the cognitive changes in vivo but not seizures. Hence, it remains unclear whether LGI1-autoantibodies are sufficient to cause seizures.

We tested this with the molecularly precise monoclonal antibodies directed against LGI1 [LGI1-monoclonal antibodies (mAbs)], derived from patient circulating B cells. These were directed towards both major domains of LGI1, leucine-rich repeat and epitempin repeat, and infused intracerebroventricularly over 7 days into juvenile male Wistar rats using osmotic pumps. Continuous wireless EEG was recorded from a depth electrode placed in hippocampal CA3 plus behavioural tests for memory and hyperexcitability were performed. Following infusion completion (Day 9), post-mortem brain slices were studied for antibody binding and effects on Kv1.1.

The LGI1-mAbs bound most strongly in the hippocampal CA3 region and induced a significant reduction in Kv1.1 cluster number in this subfield. By comparison to control-Ab injected rats video-EEG analysis over 9 days revealed convulsive and non-convulsive seizure activity in rats infused with LGI1-mAbs, with a significant number of ictal events. Memory was not impaired in the novel object recognition test.

Peripherally-derived human LGI1-mAbs infused into rodent CSF provide strong evidence of direct in vivo epileptogenesis with molecular correlations. These findings fulfill criteria for LGI1-antibodies in seizure causation.

Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Publisher copy:
10.1093/brain/awae129

Authors

More by this author
Role:
Author
ORCID:
0000-0002-2032-1472
More by this author
Role:
Author
ORCID:
0000-0003-3317-9433


More from this funder
Funder identifier:
https://ror.org/029chgv08
Grant:
104079/Z/14/Z
More from this funder
Funder identifier:
https://ror.org/03x94j517
Grant:
MR/V007173/1


Publisher:
Oxford University Press
Journal:
Brain More from this journal
Volume:
147
Issue:
8
Pages:
2636-2642
Publication date:
2024-04-25
Acceptance date:
2024-04-05
DOI:
EISSN:
1460-2156
ISSN:
0006-8950
Pmid:
38662480


Language:
English
Keywords:
Pubs id:
1992304
Local pid:
pubs:1992304
Deposit date:
2025-02-05
ARK identifier:

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP